TEST BANK
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy L. Wright
, TABLE OF CONTENT7i 7i
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 2. Review of Basic Principles of Pharmacology ..................................................................................... 5
7i 7i 7i 7i 7i 7i 7i
Chapter 3. Rational Drug Selection .................................................................................................................... 11
7i 7i 7i 7i
Chapter 4. Legal and Professional Issues in Prescribing .................................................................................... 14
7i 7i 7i 7i 7i 7i 7i
Chapter 5. Adverse Drug Reactions.................................................................................................................... 16
7i 7i 7i 7i
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
7i 7i 7i 7i 7i
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................. 22
7i 7i 7i 7i
Chapter 8. Herbal Therapies ............................................................................................................................... 28
7i 7i 7i
Chapter 9. Cannabis ............................................................................................................................................ 31
7i 7i
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
7i 7i
Chapter 11. Drugs Affecting the Autonomic Nervous System .......................................................................... 38
7i 7i 7i 7i 7i 7i 7i
Chapter 12. Drugs Affecting the Central Nervous System................................................................................. 45
7i 7i 7i 7i 7i 7i 7i
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................ 53
7i 7i 7i 7i 7i 7i 7i 7i
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................ 61
7i 7i 7i 7i 7i 7i
Chapter 15. Drugs Affecting the Hematological System ................................................................................... 65
7i 7i 7i 7i 7i 7i
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................ 69
7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................ 75
7i 7i 7i 7i 7i 7i 7i
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
7i 7i 7i 7i 7i 7i
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .................. 80
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ........................... 83
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 21. Drugs Affecting the Reproductive System ..................................................................................... 86
7i 7i 7i 7i 7i 7i
Chapter 22. Drugs Affecting the Bones and Joints............................................................................................. 92
7i 7i 7i 7i 7i 7i 7i
Chapter 23. Drugs Affecting the Integumentary System.................................................................................... 96
7i 7i 7i 7i 7i 7i
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
7i 7i 7i 7i 7i 7i 7i
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections....................................................... 105
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 26. Drugs Used to Treat Inflammatory Processes............................................................................... 108
7i 7i 7i 7i 7i 7i 7i
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ................................................................................. 111
7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 28. Anemia .......................................................................................................................................... 113
7i 7i
Chapter 29. Anxiety and Depression ................................................................................................................ 116
7i 7i 7i 7i
Chapter 30. Attention Deficit-Hyperactivity Disorder ..................................................................................... 120
7i 7i 7i 7i
Chapter 31. Asthma and Allergy ...................................................................................................................... 122
7i 7i 7i 7i
Chapter 32. Chronic Obstructive Pulmonary Disease ...................................................................................... 125
7i 7i 7i 7i 7i
Chapter 33. Contraception ................................................................................................................................ 127
7i 7i
Chapter 34. COVID-19: Acute and Chronic .................................................................................................... 130
7i 7i 7i 7i 7i
Chapter 35. Dermatological Conditions ........................................................................................................... 134
7i 7i 7i
Chapter 36. Diabetes Management ................................................................................................................... 138
7i 7i 7i
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ..................................................................... 146
7i 7i 7i 7i 7i 7i 7i
Chapter 38. Headaches...................................................................................................................................... 149
7i 7i
Chapter 39. Heart Failure .................................................................................................................................. 153
7i 7i 7i
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ........................................................... 158
7i 7i 7i 7i 7i 7i 7i
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
7i 7i 7i 7i
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
7i 7i
Chapter 43. Hypertension ................................................................................................................................. 169
7i 7i
Chapter 44. Hyperthyroidism and Hypothyroidism ......................................................................................... 174
7i 7i 7i 7i
Chapter 45. Obesity .......................................................................................................................................... 177
7i 7i
Chapter 46. Pain Management: Acute and Chronic Pain ................................................................................. 181
7i 7i 7i 7i 7i 7i 7i
Chapter 47. Pneumonia ..................................................................................................................................... 185
7i 7i
Chapter 48. Sexually Transmitted Diseases and Vaginitis ............................................................................... 187
7i 7i 7i 7i 7i 7i
Chapter 49. Substance Use Disorders ............................................................................................................... 190
7i 7i 7i 7i
Chapter 50. Tuberculosis .................................................................................................................................. 195
7i 7i
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ......... 197
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
7i 7i 7i 7i
Chapter 53. Women as Patients ........................................................................................................................ 203
7i 7i 7i 7i
Chapter 54. Men as Patients ............................................................................................................................. 207
7i 7i 7i 7i
Chapter 55. Pediatric Patients ........................................................................................................................... 209
7i 7i 7i
Chapter 57. Geriatric Patients ........................................................................................................................... 213
7i 7i 7i
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e 7i 7i 7i 7i Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
MULTIPLE CHOICE 7i
1. Nurse practitioner prescriptive authority is regulated by:
7i 7i 7i 7i 7i 7i
A. The National Council of State Boards of Nursing
7i 7i 7i 7i 7i 7i 7i
B. The U.S. Drug Enforcement Administration
7i 7i 7i 7i
C. The State Board of Nursing for each state
7i 7i 7i 7i 7i 7i 7i
D. The State Board of Pharmacy
7i 7i 7i 7i
ANS: C 7 i PTS: 7 i 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriberi
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
both in their basic nursing program and in their APRN program.
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
B. Nurses care for the patient from a holistic approach and include the patient in
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
decision-making regarding their care. 7i 7i 7i
C. APRNs are less likely to prescribe narcotics and other controlled substances.
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
D. APRNs are able to prescribe independently in all states, whereas a physician’s
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
assistant needs to have a physician supervising their practice.
7i 7i 7i 7i 7i 7i 7i 7i
ANS: B 7 i PTS: 7 i 1
3. Clinical judgment in prescribing includes:
7i 7i 7i 7i
A. Factoring in the cost to the patient of the medication prescribed
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
B. Always prescribing the newest medication available for the disease process
7i 7i 7i 7i 7i 7i 7i 7i 7i
C. Handing out drug samples to poor patients7i 7i 7i 7i 7i 7i
D. Prescribing all generic medications to cut costs 7i 7i 7i 7i 7i 7i
ANS: A 7 i PTS: 7 i 1
4. The process for choosing an effective drug for a disorder includes:
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
A. Asking the patient what drug they think would work best for them
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
B. Consulting nationally recognized guidelines for disease management
7i 7i 7i 7i 7i 7i
C. Prescribing medications that are available as samples before writing a prescription
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
7i 7i 7i 7i 7i 7i 7i
ANS: B 7 i PTS: 7 i 1
5. Nonintentional nonadherence of drug therapy may occur due to:
7i 7i 7i 7i 7i 7i 7i 7i
A. Belief that medication does not work
7i 7i 7i 7i 7i
B. Adverse drug reactions 7i 7i
C. Chronic conditions that require daily therapy
7i 7i 7i 7i 7i
D. Forgetfulness or distraction 7i 7i
ANS: D 7 i PTS: 7 i 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy L. Wright
, TABLE OF CONTENT7i 7i
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 2. Review of Basic Principles of Pharmacology ..................................................................................... 5
7i 7i 7i 7i 7i 7i 7i
Chapter 3. Rational Drug Selection .................................................................................................................... 11
7i 7i 7i 7i
Chapter 4. Legal and Professional Issues in Prescribing .................................................................................... 14
7i 7i 7i 7i 7i 7i 7i
Chapter 5. Adverse Drug Reactions.................................................................................................................... 16
7i 7i 7i 7i
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
7i 7i 7i 7i 7i
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................. 22
7i 7i 7i 7i
Chapter 8. Herbal Therapies ............................................................................................................................... 28
7i 7i 7i
Chapter 9. Cannabis ............................................................................................................................................ 31
7i 7i
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
7i 7i
Chapter 11. Drugs Affecting the Autonomic Nervous System .......................................................................... 38
7i 7i 7i 7i 7i 7i 7i
Chapter 12. Drugs Affecting the Central Nervous System................................................................................. 45
7i 7i 7i 7i 7i 7i 7i
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................ 53
7i 7i 7i 7i 7i 7i 7i 7i
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................ 61
7i 7i 7i 7i 7i 7i
Chapter 15. Drugs Affecting the Hematological System ................................................................................... 65
7i 7i 7i 7i 7i 7i
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................ 69
7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................ 75
7i 7i 7i 7i 7i 7i 7i
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
7i 7i 7i 7i 7i 7i
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .................. 80
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ........................... 83
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 21. Drugs Affecting the Reproductive System ..................................................................................... 86
7i 7i 7i 7i 7i 7i
Chapter 22. Drugs Affecting the Bones and Joints............................................................................................. 92
7i 7i 7i 7i 7i 7i 7i
Chapter 23. Drugs Affecting the Integumentary System.................................................................................... 96
7i 7i 7i 7i 7i 7i
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
7i 7i 7i 7i 7i 7i 7i
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections....................................................... 105
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 26. Drugs Used to Treat Inflammatory Processes............................................................................... 108
7i 7i 7i 7i 7i 7i 7i
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ................................................................................. 111
7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 28. Anemia .......................................................................................................................................... 113
7i 7i
Chapter 29. Anxiety and Depression ................................................................................................................ 116
7i 7i 7i 7i
Chapter 30. Attention Deficit-Hyperactivity Disorder ..................................................................................... 120
7i 7i 7i 7i
Chapter 31. Asthma and Allergy ...................................................................................................................... 122
7i 7i 7i 7i
Chapter 32. Chronic Obstructive Pulmonary Disease ...................................................................................... 125
7i 7i 7i 7i 7i
Chapter 33. Contraception ................................................................................................................................ 127
7i 7i
Chapter 34. COVID-19: Acute and Chronic .................................................................................................... 130
7i 7i 7i 7i 7i
Chapter 35. Dermatological Conditions ........................................................................................................... 134
7i 7i 7i
Chapter 36. Diabetes Management ................................................................................................................... 138
7i 7i 7i
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ..................................................................... 146
7i 7i 7i 7i 7i 7i 7i
Chapter 38. Headaches...................................................................................................................................... 149
7i 7i
Chapter 39. Heart Failure .................................................................................................................................. 153
7i 7i 7i
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ........................................................... 158
7i 7i 7i 7i 7i 7i 7i
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
7i 7i 7i 7i
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
7i 7i
Chapter 43. Hypertension ................................................................................................................................. 169
7i 7i
Chapter 44. Hyperthyroidism and Hypothyroidism ......................................................................................... 174
7i 7i 7i 7i
Chapter 45. Obesity .......................................................................................................................................... 177
7i 7i
Chapter 46. Pain Management: Acute and Chronic Pain ................................................................................. 181
7i 7i 7i 7i 7i 7i 7i
Chapter 47. Pneumonia ..................................................................................................................................... 185
7i 7i
Chapter 48. Sexually Transmitted Diseases and Vaginitis ............................................................................... 187
7i 7i 7i 7i 7i 7i
Chapter 49. Substance Use Disorders ............................................................................................................... 190
7i 7i 7i 7i
Chapter 50. Tuberculosis .................................................................................................................................. 195
7i 7i
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ......... 197
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
7i 7i 7i 7i
Chapter 53. Women as Patients ........................................................................................................................ 203
7i 7i 7i 7i
Chapter 54. Men as Patients ............................................................................................................................. 207
7i 7i 7i 7i
Chapter 55. Pediatric Patients ........................................................................................................................... 209
7i 7i 7i
Chapter 57. Geriatric Patients ........................................................................................................................... 213
7i 7i 7i
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e 7i 7i 7i 7i Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
MULTIPLE CHOICE 7i
1. Nurse practitioner prescriptive authority is regulated by:
7i 7i 7i 7i 7i 7i
A. The National Council of State Boards of Nursing
7i 7i 7i 7i 7i 7i 7i
B. The U.S. Drug Enforcement Administration
7i 7i 7i 7i
C. The State Board of Nursing for each state
7i 7i 7i 7i 7i 7i 7i
D. The State Board of Pharmacy
7i 7i 7i 7i
ANS: C 7 i PTS: 7 i 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriberi
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
both in their basic nursing program and in their APRN program.
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
B. Nurses care for the patient from a holistic approach and include the patient in
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
decision-making regarding their care. 7i 7i 7i
C. APRNs are less likely to prescribe narcotics and other controlled substances.
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
D. APRNs are able to prescribe independently in all states, whereas a physician’s
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i i
7
assistant needs to have a physician supervising their practice.
7i 7i 7i 7i 7i 7i 7i 7i
ANS: B 7 i PTS: 7 i 1
3. Clinical judgment in prescribing includes:
7i 7i 7i 7i
A. Factoring in the cost to the patient of the medication prescribed
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
B. Always prescribing the newest medication available for the disease process
7i 7i 7i 7i 7i 7i 7i 7i 7i
C. Handing out drug samples to poor patients7i 7i 7i 7i 7i 7i
D. Prescribing all generic medications to cut costs 7i 7i 7i 7i 7i 7i
ANS: A 7 i PTS: 7 i 1
4. The process for choosing an effective drug for a disorder includes:
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
A. Asking the patient what drug they think would work best for them
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
B. Consulting nationally recognized guidelines for disease management
7i 7i 7i 7i 7i 7i
C. Prescribing medications that are available as samples before writing a prescription
7i 7i 7i 7i 7i 7i 7i 7i 7i 7i
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
7i 7i 7i 7i 7i 7i 7i
ANS: B 7 i PTS: 7 i 1
5. Nonintentional nonadherence of drug therapy may occur due to:
7i 7i 7i 7i 7i 7i 7i 7i
A. Belief that medication does not work
7i 7i 7i 7i 7i
B. Adverse drug reactions 7i 7i
C. Chronic conditions that require daily therapy
7i 7i 7i 7i 7i
D. Forgetfulness or distraction 7i 7i
ANS: D 7 i PTS: 7 i 1
